Literature DB >> 18429192

Folding and purification of insoluble (inclusion body) proteins from Escherichia coli.

P T Wingfield1, I Palmer, S M Liang.   

Abstract

Heterologous expression of recombinant proteins in E. coli often results in the formation of insoluble and inactive protein aggregates, commonly referred to as inclusion bodies. To obtain the native (i.e., correctly folded) and hence active form of the protein from such aggregates, four steps are usually followed: (1) the cells are lysed and the are aggregates, (2) the cell wall and outer membrane components of the aggregates are removed, (3) the aggregates are solubilized (or extracted) with strong protein denaturants, and (4) the solubilized, denatured proteins are folded with concomitant oxidation of reduced cysteine residues into the correct disulfide bonds to obtain the native protein. This unit features three different approaches to the final step of protein folding and purification. In the first, guanidine HCl is used as the denaturant, after which the solubilized protein is folded (before purification) in an "oxido-shuffling" buffer system to increase the rate of protein oxidation. In the second, acetic acid is used to solubilize the protein which is then partially purified by gel filtration before folding, and then the protein is folded and oxidized by simple dialyzed against water. A Support Protocol is included for rapidly determining the amount of folded protein that contains the correct disulfide linkage pattern. Finally, folding and purification of a fusion protein is described using metal-chelate affinity chromatography.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 18429192     DOI: 10.1002/0471140864.ps0605s00

Source DB:  PubMed          Journal:  Curr Protoc Protein Sci        ISSN: 1934-3655


  6 in total

1.  Refolding process of cysteine-rich proteins:Chitinase as a model.

Authors:  Malihe Moghadam; Ali Ganji; Abdolreza Varasteh; Reza Falak; Mojtaba Sankian
Journal:  Rep Biochem Mol Biol       Date:  2015-10

2.  Comparative study of immunological and structural properties of two recombinant vaccine candidates against botulinum neurotoxin type E.

Authors:  Mosayeb Rostamian; Seyed Jafar Mousavy; Firouz Ebrahimi; Seyyed Abolghasem Ghadami; Nader Sheibani; Mohammad Ebrahim Minaei; Mohammad Ali Arefpour Torabi
Journal:  Iran Biomed J       Date:  2012

3.  Enhanced in vitro refolding of fibroblast growth factor 15 with the assistance of SUMO fusion partner.

Authors:  Bo Kong; Grace L Guo
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

4.  Structural basis for the recognition of spliceosomal SmN/B/B' proteins by the RBM5 OCRE domain in splicing regulation.

Authors:  André Mourão; Sophie Bonnal; Komal Soni; Lisa Warner; Rémy Bordonné; Juan Valcárcel; Michael Sattler
Journal:  Elife       Date:  2016-11-29       Impact factor: 8.140

5.  Soluble expression of disulfide bond containing proteins FGF15 and FGF19 in the cytoplasm of Escherichia coli.

Authors:  Bo Kong; Grace L Guo
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

6.  Decorated networks of native proteins: nanomaterials with tunable mesoscopic domain size.

Authors:  Ioatzin Ríos de Anda; Angélique Coutable-Pennarun; Christopher Brasnett; Stephen Whitelam; Annela Seddon; John Russo; J L Ross Anderson; C Patrick Royall
Journal:  Soft Matter       Date:  2021-07-07       Impact factor: 3.679

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.